Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.
Industry News
Sanger Institute Builds Genome Sequencing Facility
The Wellcome Trust Sanger Institute will open a $42 million genome sequencing facility in August of 2015 in Hinxton in the United Kingdom. The three-story, 51,667-sf project is located near Cambridge on the Institute's biomedical research campus. The sequencing facility is an integral part of the master plan for the site, which will include a 38,750-sf bio-data innovation center. The Sanger Institute is operated by Genome Research Limited, a wholly owned subsidiary of the Wellcome Trust.
Banner-University Medical Center Plans Tucson Inpatient Tower
Banner-University Medical Center is planning to begin construction in early 2016 on a $400 million inpatient tower in Tucson. Designed by Shepley Bulfinch and GLHN Architects and Engineers, the 11-story, 689,000-sf facility will initially provide 240 private patient rooms, with two floors of shell space to accommodate 96 additional beds as needed. The project will also include 22 operating rooms, advanced imaging suites, and public areas.
North Carolina A&T State University Plans Student Center
North Carolina A&T State University began site work in June of 2015 for a $90 million student center in Greensboro, N.C. The three-story, 150,000-sf facility will provide a central commons area, a 500-seat lecture hall, conference and study rooms, offices, restaurants, a bookstore, and a 250-seat dining facility. The project was designed by Cannon Design and Vines Architecture and is being built by a partnership of Balfour Beatty Construction, D.H.
University of Glasgow Plans Imaging Centre of Excellence
The University of Glasgow began construction in fall of 2015 on the $25 million Imaging Centre of Excellence at the South Glasgow Hospitals Campus in Scotland. Designed by BMJ Architects, the project includes redevelopment of an existing building to provide advanced medical research space for neurological and cardiovascular conditions and will feature a 7-Tesla clinical MRI scanner.
Green Cross Biotherapeutics Builds Montreal Facility
Green Cross Biotherapeutics began building a $256 million biopharmaceutical manufacturing facility in Canada in June of 2015. Located on the Montreal Technoparc's Saint-Laurent Campus, the project will support the production of intravenous immunoglobulin (IVIG) and albumin products, and will act as the company's North American headquarters. The 225,000-gsf facility is expected to be fully operational in 2019 and will accommodate 200 scientists, engineers, and support staff. Green Cross Biotherapeutics is headquartered Yongin, South Korea.